Clinical Trial Update: Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL) [Phase 1]

View source ↗

Summary

Phase 1 trial of lenalidomide plus plerixafor in previously treated chronic lymphocytic leukemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Lenalidomide (lenalidomide)
• Plerixafor (Plerixafor)

Snippet

Sponsor: David Rizzieri, MD | Conditions: Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 | Status: COMPLETED | Results posted: 2018-02-05